RGEN: Repligen Company Short-Term Debts

Public company logo of Repligen Corporation (RGEN)

Repligen Corporation (RGEN) leads in filtration and chromatography automation for biopharmaceuticals. The short-term debt dynamics, with chart data sourced from GURU.Markets, demonstrate stability, while 0.08 characterizes this valuation parameter. Market capitalization is based on the sale of analytical instruments and systems. Constant demand for consumables ensures a steady cash flow and high business profitability.

RGEN Repligen Current Liabilities (07/04/2022 - 10/29/2026)

Metric breakdowns and analytics for Repligen Inc. (RGEN)

- current quotes and average value forecast:
Price Chart Repligen|RGEN - Fair Value Consensus
- market capitalization information:
Market Capitalization Repligen Corporation|RGEN - Total Enterprise Value
- business book valuation details:
Net Assets per Single Share Repligen|RGEN - Net Asset Value|Market Value to Book Value Ratio repligen.com|RGEN - Aggregate Company Assets
- debt and liquidity details:
Total Debt to Capital Repligen Corporation|RGEN - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital Repligen Corporation|RGEN - Company Total Indebtedness|Debts to Book Capitalization Repligen Corporation|RGEN - Long-Term Debt|Company Short-Term Debt Repligen|Quick Liquidity Indicator repligen.com
- earnings and multiples data:
RGEN - Final Profit
Comprehensive company analysis:Repligen (RGEN)
Manufactured products of Repligen Inc.

Short-term debt measures the volume of credit obligations due within one year, reflecting current liquidity and the efficiency of working capital management. An analysis of borrowings with a maturity of up to one year allows for an assessment of the financial stability of Repligen Corporation (RGEN), which is supported by its strategic status in bioprocessing equipment and the absence of geopolitical risks within global supply chains.

Main competitors

TEM - Company Short-Term Debt|Company Short-Term Loans and Borrowings QGEN (Qiagen NV)|IONS: Company Short-Term Debts|Short-Term Debt Avidity Corp (RNA)|Company Short-Term Debt CRISPR Therapeutics AG|genedx.com - Current Liabilities|Company Short-Term Debt Ultragenyx (RARE)|Company Short-Term Debt BEAM (Beam Therapeutics Inc)|Company Short-Term Debts SRPT (Sarepta Therapeutics Inc)|Short-Term Debt Volume Twist Bioscience Corp (TWST)|10x Genomics, Inc. - Company Short-Term Debts|Short-Term Indebtedness intelliatx.com (NTLA)|STOK: Company Short-Term Debts|Short-Term Debt BioLife Solutions Inc (BLFS)|Company Short-Term Debt Wave Life Sciences Corp|Company Short-Term Indebtedness MAZE (Maze Therapeutics Corp)|Company Current Liabilities SION (Sionna Therapeutics Inc)|PRME (primemedicine.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts TSHA (Taysha Gene Therapies, Inc.)|QURE - Company Current Liabilities|MGTX - Company Short-Term Debt|Short-Term Debt REGENXBIO Corp|Solid Biosciences Inc. (SLDB) - Company Short-Term Debt|ocugen.com - Company Short-Term Loans and Borrowings|Company Short-Term Debt PacBio|Benitec Biopharma Inc - Current Liabilities|Company Short-Term Debt Design Pharma (DSGN)|RCKT - Short-Term Debt|Company Short-Term Debt 4D Molecular Therapeutics FDMT|Company Short-Term Loans and Borrowings LXEO|Korro Bio, Inc - Company Short-Term Debts|EDIT - Company Short-Term Debts|SLN (Silence Therapeutics Inc.) - Company Current Liabilities|PRQR: Amount of Current Liabilities|CDXS (Codexis Inc) - Company Short-Term Debts|sangamo.com (SGMO) - Short-Term Debt Volume|Company Short-Term Debt Nautilus Biotechnology (NAUT)|MGX - Short-Term Debt|Company Short-Term Debt Precision BioSciences DTIL|GBIO: Company Short-Term Indebtedness|BOLD - Company Short-Term Debt|Company Short-Term Loans and Borrowings XCUR (Exicure, Inc.)|IMNN: Company Short-Term Debts|Short-Term Indebtedness Phio Pharmaceuticals Corp. PHIO|MBIO (Mustang Bio Inc) - Company Short-Term Debts|Short-Term Debt TransCode RNAZ|Company Short-Term Debt Bionano Genomics, Inc. (BNGO)|adnas.com - Company Short-Term Indebtedness|Company Short-Term Debts BLUE (bluebird bio)|IPA: Company Short-Term Indebtedness|OMGA - Company Short-Term Debt|OMIC (Singular Genomics Corp) - Company Short-Term Indebtedness|RGLS: Company Short-Term Debts|syros.com (SYRS) - Company Short-Term Debts|Company Short-Term Debt Telesis Bio|TCON: Company Short-Term Loans and Borrowings|Company Short-Term Debts UBX